Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
Review

Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment

Y. Yang V. Vasudevaraja J. Serrano H. Mohamed S. Kelly G. Jour T. Gindin K. Park D. Jones X. Feng J. Pinnell S. Mclennan M. Tin A. Tsirigos M. Snuderl K. Wrzeszczynski
Sep 2026 · medRxiv · 0 citations
Medicine

TL;DR

The technical challenges of validating an NGS oncological diagnostic targeted assay for clinical grade accuracy and sensitivity for patient care are presented and how copy number alterations provide a more comprehensive description of the tumors genomic profile are shown.

DOI Semantic Scholar
View source

Similar papers

Aug 2026

Transforming routine solid tumor profiling with automated next-generation sequencing: experience from a reference general hospital.

Screening tumor types for which a first-line, integrated DNA-RNA NGS strategy provides a valuable advantage for rapid therapeutic decisions demonstrates that integrated DNA-RNA high-throughput NGS enables timely, precise molecular profiling for personalized therapy in solid tumors.

A. Destro, Federica Panebianco, Cecília Durães et al. · 0 citations
Open access Aug 2026

Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer

Triple-negative breast cancer (TNBC) is characterized by aggressive behaviour, high tumor heterogeneity, and an increased likelihood of recurrence and early metastasis. These factors hinder successful treatment. Genetic diagnosis enables personalized clinical recommendations and treatment options. The objective of this...

D. Alzate, A. Y. Sánchez, Yovana Pacheco et al. · 0 citations
Review Open access Aug 2026

Comparison of whole-exome, whole-transcriptome genomic profiling and targeted sequencing with 50-gene panels in advanced solid tumors

The value of genomic profiling in advanced solid tumors using whole-exome, whole-transcriptome sequencing (WES/WTS) in comparison to 50-gene panels is evaluated to identify potential matched therapies, thereby informing clinical decision-making and potentially improving outcomes for more patients.

J. De La O, David W Hall, Jess R. Hoag et al. · 0 citations
Open access Sep 2026

The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers.

Analysis of circulating tumor-DNA (ctDNA) provides a molecular assessment that can complement routine imaging in childhood cancer management. Detailed monitoring of ctDNA levels may provide information on treatment efficacy and resistance, minimal residual disease and allows for early detection of relapse. Here, tumor-...

T. Österlund, Daniel Andersson, Raghda R. Ibrahim et al. · 0 citations
Open access Sep 2026

Real world genomic profiling in non-small cell lung cancer reveals regional variations with clinical implications

Routine genomic profiling in NSCLC provides clinically relevant information beyond actionable driver detection when interpreted together with stage, smoking history, age, sex, and regional molecular context, and support a more context-aware interpretation of routine molecular diagnostics in thoracic oncology.

N. Karlowatz, L. Kohn, C. Patthey et al. · 0 citations
Open access Aug 2026

Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series

The findings support implementing testing for use of a safe, inexpensive repurposed drug and underscore the importance of upfront testing for timely treatment decision-making and implementation of trial findings into routine practice.

L. Kerrin, Osamah Al Haddad, Ellen Reid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.